Sirona Biochem Corp. (SBM.V)
- GlobeNewswire
Sirona Biochem CEO Quarterly Update
VANCOUVER, British Columbia, April 11, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to provide the following update to shareholders. Dear shareholders, We continue to make fundamental progress on core objectives and will be able to share more in due course. TFC-1067 A comprehensive update is due in the near future. We can report there are no adverse events and proper disclosure rules are being followed. No further information will be ma
- GlobeNewswire
Sirona Biochem Subsidiary, TFChem, Awarded Financing in Partnership with French Government
VANCOUVER, British Colombia, March 09, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that its wholly owned subsidiary TFChem, has been awarded financing to develop an advanced chemistry process that could improve the manufacturing of active ingredients. The project will be financed in partnership with the French government and will include the University of Rouen in Normandy, the Engineering school INSA of Rouen and the CN
- GlobeNewswire
Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support
VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has renewed an agreement with Luxembourg-based analytics and marketing specialist CURE Intelligence for marketing intelligence services and communications support. The agreement has been signed for an additional year of services. “We have been utilizing the powerful tools provided by CURE Intelligence which keep us informed on relev
